1. Pinkston JA, Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg 1999;120:834–40.
2. O’Brien CJ. Current management of benign parotid tumors: the role of limited superficial parotidectomy. Head Neck 2003;25:946–52.
3. Bron LP, O’Brien CJ. Facial nerve function after parotidectomy. Arch Otolaryngol Head Neck Surg 1997;123:1091–6.
4. Dulguerov P, Marchal F, Lehmann W. Postparotidectomy facial nerve paralysis: possible etiologic factors and results with routine facial nerve monitoring. Laryngoscope 1999;109:754–62.
5. Eisele DW, Wang SJ, Orloff LA. Electrophysiologic facial nerve monitoring during parotidectomy. Head Neck 2010;32:399–405.
6. Guntinas-Lichius O, Gabriel B, Klussmann JP. Risk of facial palsy and severe Frey’s syndrome after conservative parotidectomy for benign disease: analysis of 610 operations. Acta Otolaryngol 2006;126:1104–9.
9. Rea PM, McGarry G, Shaw-Dunn J. The precision of four commonly used surgical landmarks forlocating the facial nerve in anterograde parotidectomy in humans. Ann Anat 2010;192:27–32.
10. Ariyoshi Y, Shimahara M. Determining whether a parotid tumor is in the superficial or deep lobe using magnetic resonance imaging. J Oral Maxillofac Surg 1998;56:23–6.
11. Divi V, Fatt MA, Teknos TN, Mukherji SK. Use of cross-sectional imaging in predicting surgical location of parotid neoplasms. J Comput Assist Tomogr 2005;29:315–9.
16. Beaumont T, Ideias PC, Rimlinger M, Broggio D, Franck D. Development and test of sets of 3D printed age-specific thyroid phantoms for
131I measurements. Phys Med Biol 2017;62:4673–93.